BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang J, Jin MS, Suo J, Wang YP, He L, Cao XY. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors. World J Gastroenterol 2012; 18(20): 2569-2575 [PMID: 22654456 DOI: 10.3748/wjg.v18.i20.2569]
URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2569.htm
Number Citing Articles
1
Tadashi Kondo. ProteogenomicsAdvances in Experimental Medicine and Biology 2016; 926: 139 doi: 10.1007/978-3-319-42316-6_9
2
Duraisamy Ramachandhiran, Veerasamy Vinothkumar, Sukumar Babukumar. Paeonol exhibits anti-tumor effects by apoptotic and anti-inflammatory activities in 7,12-dimethylbenz(a)anthracene induced oral carcinogenesisBiotechnic & Histochemistry 2019; 94(1): 10 doi: 10.1080/10520295.2018.1493221
3
Michaela Angelika Ihle, Sebastian Huss, Wiebke Jeske, Wolfgang Hartmann, Sabine Merkelbach-Bruse, Hans-Ulrich Schildhaus, Reinhard Büttner, Harri Sihto, Kirsten Sundby Hall, Mikael Eriksson, Peter Reichardt, Heikki Joensuu, Eva Wardelmann, Anette Duensing. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatmentPLOS ONE 2018; 13(2): e0193048 doi: 10.1371/journal.pone.0193048
4
Yu Zhou, Wenqing Hu, Ping Chen, Masanobu Abe, Lei Shi, Si-yuan Tan, Yong Li, Liang Zong. Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumorsMedicine 2017; 96(34): e7911 doi: 10.1097/MD.0000000000007911
5
Erika P. Berger, Chad M. Johannes, Albert E. Jergens, Karin Allenspach, Barbara E. Powers, Yingzhou Du, Jonathan P. Mochel, Leslie E. Fox, Margaret L. Musser. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogsJournal of Veterinary Internal Medicine 2018; 32(6): 2045 doi: 10.1111/jvim.15335
6
Nurten Turkel Kucukmetin, Bahattin Cicek, Murat Saruc, Ozdal Ersoy, Eser Vardareli, Oguz Onder, Ercument Gurluler, Arzu Tiftikci, Suha Goksel, Nurdan Tozun. Ki67 as a prognostic factor for long-term outcome following surgery in gastrointestinal stromal tumorsEuropean Journal of Gastroenterology & Hepatology 2015; 27(11): 1276 doi: 10.1097/MEG.0000000000000454
7
Chiao-En Wu, Chiao-Ping Chen, Wen-Kuan Huang, Yi-Ru Pan, Erhan Aptullahoglu, Chun-Nan Yeh, John Lunec. p53 as a biomarker and potential target in gastrointestinal stromal tumorsFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.872202
8
Ugne Gyvyte, Rokas Lukosevicius, Ruta Inciuraite, Greta Streleckiene, Greta Gudoityte, Justina Bekampyte, Serena Valentini, Violeta Salteniene, Paulius Ruzgys, Saulius Satkauskas, Kristina Zviniene, Juozas Kupcinskas, Jurgita Skieceviciene. The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal TumorsInternational Journal of Molecular Sciences 2020; 21(14): 5151 doi: 10.3390/ijms21145151
9
Shan‐Shan Shi, Nan Wu, Yan He, Xue Wei, Qiu‐Yuan Xia, Xuan Wang, Sheng‐Bin Ye, Rui Li, Qiu Rao, Xiao‐Jun Zhou. EGFR gene mutation in gastrointestinal stromal tumoursHistopathology 2017; 71(4): 553 doi: 10.1111/his.13251
10
Sarra Ben Rejeb, Dorra Aloui, Asma Ayari, Adnen Chouchen. Prognostic Significance of C-MYC and EGFR Overexpression in Gastrointestinal Stromal Tumors: An Immunohistochemical StudyApplied Immunohistochemistry & Molecular Morphology 2025; 33(1): 43 doi: 10.1097/PAI.0000000000001235
11
Chengyu Sun, Enguo Fan, Luqiao Huang, Zhengguo Zhang. Performance of radiomics in preoperative determination of malignant potential and Ki-67 expression levels in gastrointestinal stromal tumors: a systematic review and meta-analysisActa Radiologica 2024; 65(11): 1307 doi: 10.1177/02841851241285958
12
Arnaud Uguen, Gwenaël Conq, Laurent Doucet, Matthieu Talagas, Sebastian Costa, Marc De Braekeleer, Pascale Marcorelles. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumorsVirchows Archiv 2015; 467(1): 47 doi: 10.1007/s00428-015-1763-2
13
Jun-Chuan Li, Hong-Yu Zhu, Ting-Xuan Chen, Lan-Ying Zou, Xiao-Yan Wang, Hui-Chuan Zhao, Jun Xu. Roles of mTOR and p-mTOR in Gastrointestinal Stromal TumorsAsian Pacific Journal of Cancer Prevention 2013; 14(10): 5925 doi: 10.7314/APJCP.2013.14.10.5925
14
Chen Li, Ke-Lu Yang, Quan Wang, Jin-Hui Tian, Yang Li, Zhi-Dong Gao, Xiao-Dong Yang, Ying-Jiang Ye, Ke-Wei Jiang. Clinical features of multiple gastrointestinal stromal tumors: A pooling analysis combined with evidence and gap mapWorld Journal of Gastroenterology 2020; 26(47): 7550-7567 doi: 10.3748/wjg.v26.i47.7550
15
N. Iorio, R. A. Sawaya, F. K. Friedenberg. Review article: the biology, diagnosis and management of gastrointestinal stromal tumoursAlimentary Pharmacology & Therapeutics 2014; 39(12): 1376 doi: 10.1111/apt.12761
16
Ji Li, An-Ran Wang, Xiao-Dong Chen, Hong Pan, Shi-Qiang Li. Ki67 for evaluating the prognosis of gastrointestinal stromal tumors: A systematic review and meta‑analysisOncology Letters 2022; 23(6) doi: 10.3892/ol.2022.13309
17
Yongwei Xu, Bacui Zhang, Jing Wang. Gastrointestinal Stromal Tumour with Liver Metastasis Presenting as Gastric CancerDiagnostics 2023; 13(3): 376 doi: 10.3390/diagnostics13030376
18
Newton A C S Wong, Jenny Wingate, Elise Gradhand. An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild‐type gastrointestinal stromal tumoursHistopathology 2015; 67(3): 378 doi: 10.1111/his.12667
19
Midori Wakiya, Akira Okimura, Hiroshi Hirano, Satoru Tabuchi, Shigeyuki Kawachi, Hideaki Hirai, Yuichi Nagakawa, Tatsuhiko Miyazaki, Toshitaka Nagao, Munehide Nakatsugawa. Evaluation of the Ki-67 Labeling Index as a Prognostic Stratification Factor in Non-High-Risk Gastrointestinal Stromal TumorsCureus 2025;  doi: 10.7759/cureus.93440
20
Christos Vallilas, Panagiotis Sarantis, Anastasios Kyriazoglou, Evangelos Koustas, Stamatios Theocharis, Athanasios G. Papavassiliou, Michalis V. Karamouzis. Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small MoleculesInternational Journal of Molecular Sciences 2021; 22(2): 493 doi: 10.3390/ijms22020493
21
Heikki Joensuu, Peter Hohenberger, Christopher L Corless. Gastrointestinal stromal tumourThe Lancet 2013; 382(9896): 973 doi: 10.1016/S0140-6736(13)60106-3
22
Cai-Wei Yang, Xi-Jiao Liu, Si-Yun Liu, Shang Wan, Zheng Ye, Bin Song, Jian-Guo Zhou. Current and Potential Applications of Artificial Intelligence in Gastrointestinal Stromal Tumor ImagingContrast Media & Molecular Imaging 2020; 2020: 1 doi: 10.1155/2020/6058159
23
Lin Xiao, Yiding Zhang, Yajie Wang, Lede Liu, Yisheng Pan. The relationship between Ki-67 expression and imaging signs and pathological features in GISTsFrontiers in Surgery 2023; 10 doi: 10.3389/fsurg.2023.1095924
24
Heikki Joensuu. Gastrointestinal Stromal TumorsHematology/Oncology Clinics of North America 2013; 27(5): 889 doi: 10.1016/j.hoc.2013.07.004
25
Qing‐Wei Zhang, Yun‐Jie Gao, Ran‐Ying Zhang, Xiao‐Xuan Zhou, Shuang‐Li Chen, Yan Zhang, Qiang Liu, Jian‐Rong Xu, Zhi‐Zheng Ge. Personalized CT‐based radiomics nomogram preoperative predicting Ki‐67 expression in gastrointestinal stromal tumors: a multicenter development and validation cohortClinical and Translational Medicine 2020; 9(1) doi: 10.1186/s40169-020-0263-4